# UltraTech Cement (NSE: ULTRACEMCO) share analysis

Canonical: https://vestmind.in/stocks/ultratech-cement  
Source: VestCall by Vestmind, price as of 14 October 2026.

> UltraTech Cement (NSE: ULTRACEMCO) was trading at ₹10,820 on 14 October 2026. VestCall scores its business health 62/100 (adequate). On valuation, the price sits in the “Fairly Valued” zone (₹10,752.62 – ₹11,058.51) — inside the modelled fair-value range. This is a reading of the evidence, not a buy or sell recommendation.

## Valuation zones

| Zone | Price band | Meaning |
| --- | --- | --- |
| Deeply Discounted | ₹10,034.52 – ₹10,639.88 | Furthest below the modelled fair-value range |
| Attractive Valuation | ₹10,639.88 – ₹10,752.62 | Below the modelled fair-value range |
| Fairly Valued (current) | ₹10,752.62 – ₹11,058.51 | Inside the modelled fair-value range |
| Valuation Premium | ₹11,058.51 and above | Above the modelled fair-value range |

## The case for and against

- Supports — Shareholding Quality 88/100
- Supports — Management Stability 67/100
- Supports — Growth 64/100
- Supports — Financial Strength 61/100
- Needs proof — Business Quality 50/100
- Needs proof — Capital Allocation 53/100

## Key ratios

| Ratio | UltraTech Cement | Sector median |
| --- | --- | --- |
| P/E | 12.27x | — |
| P/B | 0.67x | — |
| P/S | 0.56x | — |
| Return on equity (ROE) | 11.0% | — |
| Return on capital employed (ROCE) | 14.6% | — |
| Operating margin | 12.3% | — |
| Net margin | 9.2% | — |
| Current ratio | 0.71x | — |

## Bull, base and bear case (model outputs, not forecasts)

| Scenario | Modelled CAGR | Weight | Assumption |
| --- | --- | --- | --- |
| Bear | +0.8% | 19% | Growth decelerates to 4.8% and the multiple de-rates toward the cohort's trough. |
| Base | +13.3% | 55% | Earnings compound near the measured 13.3% and the multiple drifts toward its quality-adjusted warranted level. |
| Bull | +22.1% | 26% | Growth holds at 18.6% and the market pays the full premium the measured quality supports. |

## Questions

### Is UltraTech Cement overvalued or undervalued?

At ₹10,820, UltraTech Cement sits in VestCall’s “Fairly Valued” zone (₹10,752.62 – ₹11,058.51): inside the modelled fair-value range. Its valuation scores 88/100 (fair) against Unclassified peers. Zones describe where the price sits against modelled value; they are not an instruction to buy or sell.

### Is UltraTech Cement fundamentally strong?

VestCall scores UltraTech Cement’s business health 62/100 (adequate). The strongest measured pillars are shareholding quality and management stability. The ones that need proof are business quality and capital allocation. Each pillar is computed from reported financials, and a pillar whose inputs were not reported is excluded rather than scored as zero.

### What is UltraTech Cement’s P/E ratio?

UltraTech Cement trades at a P/E of 12.27x, on VestCall’s latest read. A multiple only means something against the business it buys: the quality-adjusted fair value on this page weighs it against UltraTech Cement’s returns and growth.

### What are the risks of investing in UltraTech Cement?

The review triggers VestCall watches for UltraTech Cement are: return on equity falls below the quality floor (roe below 15%); revenue growth falls below the thesis floor (revenue cagr below 8%); promoter holding drops materially (promoter holding below 56.33%, 3 points under the Mar 2026 filing). On the fundamentals, business quality is the weakest measured pillar at 50/100. A trigger is a named condition that would change the reading, published so the case against the stock is as visible as the case for it.

### Is this a recommendation to buy or sell UltraTech Cement?

No. VestCall states where UltraTech Cement’s price sits against modelled value, what supports the case and what would break it, with every figure sourced. It does not issue buy, sell or hold calls or price targets. Vestmind is not a SEBI-registered investment adviser or research analyst, and nothing on this page is personalised investment advice.

---

Vestmind is not a SEBI-registered investment adviser or research analyst. This is research for information, not a recommendation or personalised investment advice.